AGIO - Agios Pharmaceuticals Stock Trading

Agios Pharmaceuticals Inc.(NASDAQ: AGIO) stock trading, description, contact, officers and directors.

About Agios Pharmaceuticals Inc.

Not available

Stock Information

Agios Pharmaceuticals Inc. Company Name:

AGIO Stock Symbol:

NASDAQ Market:

Get AGIO Alerts

News, Short Squeeze, Breakout and More Instantly...

AGIO - Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma

CAMBRIDGE, Mass., Jan. 17, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today reported a full analysis of the final data, including mature overall survival (OS) results, fro...
AGIO - Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation

– Company Expects to File for Regulatory Approval for Mitapivat for the Treatment of Adults with Pyruvate Kinase (PK) Deficiency in the U.S. in Q2 2021 and in the EU in Mid-2021 – – Pivotal Trials for Mitapivat in Thalassemia on Track for Initiation in 2H 20...
AGIO - Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021

CAMBRIDGE, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today announced that the company is scheduled to present at the virtual 39th Annual J.P. Morgan Healt...